What is Simply CBD?
Headquartered in Springfield, Illinois, Simply CBD operates as a specialized provider of premium hemp-derived wellness products. The company maintains a rigorous focus on quality assurance, utilizing FDA-approved laboratory facilities to manufacture a diverse portfolio that includes CBD oils, capsules, topicals, and pet-specific formulations. By prioritizing non-GMO, organically grown hemp and implementing comprehensive third-party testing, Simply CBD has carved out a distinct niche in the competitive wellness landscape. Their business model is designed to serve a growing demographic of health-conscious consumers who prioritize transparency, purity, and efficacy in their natural health regimens.
How much funding has Simply CBD raised?
Simply CBD has raised a total of $32K across 1 funding round:
Debt
$32K
Debt (2021): $32K with participation from PPP
Key Investors in Simply CBD
PPP
Public-Private Partnership
What's next for Simply CBD?
The infusion of capital from this latest round is earmarked for strategic scaling initiatives, likely focusing on supply chain optimization and market penetration. As the company transitions through its current Series B/C stage, the focus will shift toward broadening its distribution channels and enhancing its product development pipeline. By leveraging this financial backing, Simply CBD is poised to solidify its standing as a leader in the natural wellness sector, potentially exploring new therapeutic applications for its existing product lines while maintaining the stringent quality standards that have defined its brand identity thus far.
See full Simply CBD company page
